查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953790

體外診斷契約製造市場－全球產業規模、佔有率、趨勢、機會及預測（依設備類型、技術、服務類型、地區及競爭格局分類，2021-2031年）

IVD Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type, By Technology, By Service Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球體外診斷設備契約製造市場預計將從 2025 年的 195.2 億美元成長到 2031 年的 379.3 億美元，複合年成長率達到 11.71%。

該市場將體外診斷試劑、試劑和儀器的生產外包給專業的第三方機構，從而確保符合監管要求並提高營運效率。推動這一成長的關鍵因素是慢性病和感染疾病在全球範圍內的日益流行，這反過來又需要擴充性的檢測解決方案和大規模生產能力。此外，不斷增加的成本壓力也促使原始設備製造商 (OEM) 與外部供應商合作，這使他們能夠在降低供應鏈風險的同時，減少設備方面的資本支出。

市場概覽
預測期 2027-2031
市場規模：2025年 195.2億美元
市場規模：2031年 379.3億美元
複合年成長率：2026-2031年 11.71%
成長最快的細分市場 免疫檢測
最大的市場 北美洲

然而，市場擴張的一大障礙是國際法規結構的日益收緊，這造成了合規瓶頸和財務壓力。向這些更嚴格的標準過渡需要大量的臨床證據和文件，這將顯著影響生產週期。據歐洲醫療技術協會（MedTech Europe）稱，到2024年，根據新的體外診斷醫療設備法規（IVDR），認證和維修成本可能比先前的指令增加高達100%。監管成本的大幅成長迫使製造商轉移關鍵資源，扼殺了創新，並可能延遲重要診斷產品的上市。

市場促進因素

慢性病和感染疾病的日益普及是推動全球體外診斷（IVD）契約製造市場成長的主要因素，也因此對診斷產品的擴充性提出了前所未有的高要求。非傳染性疾病和病毒感染疾病的日益嚴重迫使原始設備製造商（OEM）利用契約製造組織來應對檢測量的激增，同時避免自身產能過度擴張。疾病發生率的上升也凸顯了這一需求；例如，美國癌症協會於2024年1月發布的《2024年癌症事實與數據》報告預測，美國新增癌症病例數將首次超過200萬例。日益成長的疾病負擔要求提高診斷試劑和試劑的生產效率，這也強化了第三方生產商在確保市場供應連續性方面發揮的關鍵作用。

同時，隨著原始設備製造商 (OEM) 將策略重點轉向核心競爭力及研發最佳化，並透過外包生產來尋求成本效益，他們正在重塑產業格局。製造商日益將創新與生產分離，並將資金投入高附加價值環節，而非固定生產資產。例如，羅氏公司於 2024 年 2 月發布的 2023 年年度報告顯示，其診斷部門將專門投入 17 億瑞士法郎用於研發，以加速產品組合的擴張。這些對智慧財產權的巨額投資，使得企業必須將營運執行外包給外部合作夥伴，以維持資產負債表的柔軟性。希森美康宣布將於 2024 年投資 30 億日圓在印度新建一家試劑生產工廠，也印證了這個趨勢。

市場挑戰

日益嚴格的國際法規結構正對全球體外診斷（IVD）契約製造市場的成長構成重大障礙。隨著監管機構實施更嚴格的標準，契約製造製造商被迫投入巨資升級品管系統並擴展文件能力，以確保合規性。這項要求分散了原本用於擴大生產規模和技術創新的資金和人力資源，直接影響了營運效率。因此，新診斷產品的上市流程被延長，導致從研發到大規模生產的進程顯著延遲，並限制了製造商應對緊急醫療需求的靈活性。

這些監管瓶頸導致等候核准時間延長、產能利用不足以及持續的不確定性，實際上凍結了潛在的收入來源。據歐洲醫療技術協會（MedTech Europe）稱，截至2024年，體外診斷試劑生產商完成品管系統認證或技術文件評估的平均時間約為18個月。這一漫長的過程限制了契約製造製造商快速完成大訂單的能力，減緩了市場發展勢頭，並降低了外包對優先考慮快速將診斷解決方案推向市場的原始設備製造商（OEM）的吸引力。

市場趨勢

智慧工廠自動化和工業4.0技術的應用正在革新生產線，透過整合機器人技術和即時數據分析，提高生產精度並最大限度地減少人為錯誤。契約製造製造商正積極部署互聯系統，監控複雜診斷試劑盒生產過程中的關鍵品質屬性，確保在不影響產量的前提下，符合嚴格的放行標準。這項技術革新超越了傳統的機械化，其驅動力在於對微量試劑和複雜組裝步驟進行絕對可重複性處理的需求。根據生物梅里埃公司於2025年3月發布的2024年財務報告，該公司報告的資本支出為3.46億歐元，其中大部分專門用於擴大和自動化其在美國的生產能力，以支持其業務發展。

此外，隨著企業將供應鏈韌性置於僅依賴低成本勞動力模式之上，近岸外包和區域製造策略的日益普及正在從根本上改變市場格局。為了降低跨境物流風險和地緣政治不穩定因素，原始設備製造商（OEM）正在建立更靠近終端用戶的區域生產中心，從而顯著縮短前置作業時間並降低庫存脆弱性。與集中式全球模式相比，這種策略性分散化使企業能夠更快地應對區域性健康危機和不斷變化的當地監管要求。作為這一趨勢的顯著例證，賽默飛世爾科技公司在2025年4月的新聞稿中宣布，將在未來四年內向美國追加投資20億美元，以加強國內製造業務並支持具有韌性的區域醫療供應鏈。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球體外診斷契約製造市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依設備分類（體外診斷設備、體外診斷耗材）
    • 依技術分類（免疫檢測、臨床化學、分子診斷、微生物學、血液學、凝血和止血等）
    • 依服務類型（製造服務、檢測開發服務、其他服務）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美體外診斷契約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲體外診斷契約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區體外診斷契約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲體外診斷契約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲體外診斷契約製造市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球體外診斷契約製造市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Ortho Clinical Diagnostics
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Quidel Corporation
  • BioMerieux SA

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23764

The Global IVD Contract Manufacturing Market is projected to expand from USD 19.52 Billion in 2025 to USD 37.93 Billion by 2031, achieving a compound annual growth rate of 11.71%. This market involves outsourcing the production of in vitro diagnostic tests, reagents, and instruments to specialized third-party entities, ensuring both regulatory compliance and operational efficiency. Key drivers fueling this growth include the increasing global prevalence of chronic and infectious diseases, which demands scalable testing solutions and high-volume production capabilities. Furthermore, original equipment manufacturers are increasingly driven by cost pressures to partner with external providers, allowing them to reduce capital expenditures on facilities while mitigating supply chain risks.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 19.52 Billion
Market Size 2031USD 37.93 Billion
CAGR 2026-203111.71%
Fastest Growing SegmentImmunoassay
Largest MarketNorth America

However, a major obstacle hindering market expansion is the growing stringency of international regulatory frameworks, which creates compliance bottlenecks and financial pressure. Transitioning to these rigorous standards requires extensive clinical evidence and documentation, disproportionately impacting manufacturing timelines. According to MedTech Europe, in 2024, certification and maintenance costs under the new In Vitro Diagnostic Regulation rose by up to 100% compared to previous directives. This significant increase in regulatory expenses forces manufacturers to divert essential resources, potentially stifling innovation and delaying the introduction of critical diagnostic products to the market.

Market Driver

The escalating prevalence of chronic and infectious diseases acts as a primary engine for growth in the Global IVD Contract Manufacturing Market, creating a critical need for unprecedented scalability in diagnostic production. As the burden of non-communicable diseases and viral outbreaks grows, original equipment manufacturers are compelled to utilize contract manufacturing organizations to handle surging testing volumes without overextending their internal capacities. This demand is underscored by rising disease incidence; for instance, the American Cancer Society's 'Cancer Facts & Figures 2024' report from January 2024 projects that new cancer cases in the United States will exceed 2 million for the first time. Such elevated disease burdens necessitate higher manufacturing throughput for diagnostic assays and reagents, reinforcing the vital role of third-party producers in ensuring continuous market supply.

Simultaneously, a strategic shift among OEMs toward optimizing core competencies and research and development is reshaping the sector, as companies seek cost efficiencies through outsourced fabrication. Manufacturers are increasingly separating innovation from production, allocating financial resources toward high-value discovery phases rather than fixed manufacturing assets. For example, Roche's 'Annual Report 2023', released in February 2024, indicates that its Diagnostics Division allocated CHF 1.7 billion specifically to research and development to accelerate portfolio expansion. This heavy investment in intellectual property necessitates the use of external partners for operational execution to maintain balance sheet flexibility, a trend further reflected in Sysmex Corporation's 2024 announcement of a 3 billion JPY investment to establish a new reagent manufacturing facility in India.

Market Challenge

The increasing strictness of international regulatory frameworks poses a formidable barrier to the growth of the Global IVD Contract Manufacturing Market. As regulatory bodies enforce more rigorous standards, contract manufacturing organizations must invest heavily in upgraded quality management systems and extensive documentation capabilities to remain compliant. This necessity diverts capital and personnel focus away from production scalability and technological upgrades, directly impacting operational efficiency. Consequently, the onboarding process for new diagnostic products becomes prolonged, causing significant delays in the transition from development to mass production and limiting manufacturers' agility in responding to urgent health demands.

These regulatory bottlenecks result in extended periods of uncertainty where manufacturing capacity remains underutilized while awaiting approvals, effectively freezing potential revenue streams. According to MedTech Europe, in 2024, the average time required for in vitro diagnostic manufacturers to complete Quality Management System or Technical Documentation Assessment certification was approximately 18 months. This prolonged duration restricts the ability of contract manufacturers to execute high-volume orders promptly, thereby stalling market momentum and reducing the appeal of outsourcing for original equipment manufacturers who rely on rapid speed-to-market for their diagnostic solutions.

Market Trends

The implementation of Smart Factory Automation and Industry 4.0 Technologies is revolutionizing production lines by integrating robotics and real-time data analytics to enhance precision and minimize human error. Contract manufacturing organizations are increasingly deploying interconnected systems that monitor critical quality attributes during the fabrication of complex diagnostic kits, ensuring strict adherence to release criteria without compromising throughput speed. This technological evolution is driven by the necessity to handle micro-volume reagents and intricate assembly processes with absolute reproducibility, surpassing traditional mechanization. According to bioMerieux's '2024 Financial Results' from March 2025, the company reported capital expenditures of €346 million, with a significant portion allocated specifically to the expansion and automation of its manufacturing capacities in the United States to support operational advancement.

Additionally, the increasing adoption of nearshoring and localized manufacturing strategies is fundamentally altering the geographic footprint of the market as companies prioritize supply chain resilience over models based solely on low-cost labor. To mitigate risks associated with cross-border logistics and geopolitical instability, original equipment manufacturers are establishing regional production hubs closer to end-users, thereby drastically reducing lead times and inventory vulnerabilities. This strategic decentralization allows firms to respond more swiftly to regional health crises and changing local regulatory requirements compared to centralized global models. Highlighting this trend, Thermo Fisher Scientific committed an additional $2 billion investment in the United States over four years in an April 2025 press release, aiming to enhance domestic manufacturing operations and support a resilient local healthcare supply chain.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Ortho Clinical Diagnostics
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Quidel Corporation
  • BioMerieux SA

Report Scope

In this report, the Global IVD Contract Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IVD Contract Manufacturing Market, By Device Type

  • IVD Equipment
  • IVD Consumables

IVD Contract Manufacturing Market, By Technology

  • Immunoassay
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation & Hemostasis
  • Others

IVD Contract Manufacturing Market, By Service Type

  • Manufacturing Services
  • Assay Development Services
  • Other Services

IVD Contract Manufacturing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global IVD Contract Manufacturing Market.

Available Customizations:

Global IVD Contract Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global IVD Contract Manufacturing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (IVD Equipment, IVD Consumables)
    • 5.2.2. By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others)
    • 5.2.3. By Service Type (Manufacturing Services, Assay Development Services, Other Services)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America IVD Contract Manufacturing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type
    • 6.2.2. By Technology
    • 6.2.3. By Service Type
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States IVD Contract Manufacturing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Service Type
    • 6.3.2. Canada IVD Contract Manufacturing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Service Type
    • 6.3.3. Mexico IVD Contract Manufacturing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Service Type

7. Europe IVD Contract Manufacturing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type
    • 7.2.2. By Technology
    • 7.2.3. By Service Type
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany IVD Contract Manufacturing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Service Type
    • 7.3.2. France IVD Contract Manufacturing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Service Type
    • 7.3.3. United Kingdom IVD Contract Manufacturing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Service Type
    • 7.3.4. Italy IVD Contract Manufacturing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Service Type
    • 7.3.5. Spain IVD Contract Manufacturing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Service Type

8. Asia Pacific IVD Contract Manufacturing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type
    • 8.2.2. By Technology
    • 8.2.3. By Service Type
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China IVD Contract Manufacturing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Service Type
    • 8.3.2. India IVD Contract Manufacturing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Service Type
    • 8.3.3. Japan IVD Contract Manufacturing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Service Type
    • 8.3.4. South Korea IVD Contract Manufacturing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Service Type
    • 8.3.5. Australia IVD Contract Manufacturing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Service Type

9. Middle East & Africa IVD Contract Manufacturing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type
    • 9.2.2. By Technology
    • 9.2.3. By Service Type
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia IVD Contract Manufacturing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Service Type
    • 9.3.2. UAE IVD Contract Manufacturing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Service Type
    • 9.3.3. South Africa IVD Contract Manufacturing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Service Type

10. South America IVD Contract Manufacturing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type
    • 10.2.2. By Technology
    • 10.2.3. By Service Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil IVD Contract Manufacturing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Service Type
    • 10.3.2. Colombia IVD Contract Manufacturing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Service Type
    • 10.3.3. Argentina IVD Contract Manufacturing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Service Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global IVD Contract Manufacturing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Siemens Healthineers AG
  • 15.3. Danaher Corporation
  • 15.4. F. Hoffmann-La Roche Ltd.
  • 15.5. Ortho Clinical Diagnostics
  • 15.6. Abbott Laboratories
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. Sysmex Corporation
  • 15.9. Quidel Corporation
  • 15.10. BioMerieux SA

16. Strategic Recommendations

17. About Us & Disclaimer